Recently, patients in many states have suffered complications from the use of transvaginal mesh implants used in surgeries to treat pelvic organ prolapse and similar conditions. The problems have led the U.S. Food and Drug Administration (FDA) to issue warnings against continued use of the implants in new patients. However, even before the risks of using transvaginal mesh became apparent, the U.S. Agency for Healthcare Research and Quality (AHRQ) had released guidelines for physicians that warned of the possible risks of transvaginal mesh use.
The guidelines specified that patients should know about several different issues with transvaginal mesh use, including:
- Transvaginal mesh procedures were still considered “novel,” or relatively new, methods for treating pelvic organ prolapse;
- Success rates varied and little information was available about long-term use;
- Complications, including pain, internal bleeding, and mesh breaking through internal tissues, could result; and
- Little data existed to support the idea that transvaginal mesh use was more effective than other methods of treating pelvic organ prolapse.
The guidelines also recommended that physicians, surgeons, and nurses be trained specifically in the use of transvaginal mesh to repair pelvic organ prolapse and the symptoms of the complications it could cause.
Most physicians and medical staff take their responsibilities toward patients seriously, and they strive to make sure patients understand the risks and benefits of any medical procedure. When these risks are not known or not communicated, however, serious harm can result. At Lipton Law, our dedicated Michigan transvaginal mesh injury attorneys can help you find out what happened and get the compensation you need to heal. Call us today at (248) 557-1688 for a free and confidential telephone consultation.